USPSTF Assessment
The USPSTF concludes that there is moderate certainty that the net benefit of screening all newborn infants for hearing loss is moderate.
CLINICAL CONSIDERATIONS

Patient Population Under Consideration
The patient population considered here includes all newborn infants. 
Universal Screening for Hearing Loss in
Screening tests
Screening programs should be conducted by using a 1-step or 2-step validated protocol. A frequently-used 2-step screening process involves otoacoustic emissions followed by auditory brain stem response in newborns who fail the first test.
Infants with positive screening test results should receive appropriate audiologic evaluation and follow-up after discharge.
Procedures for screening and follow-up should be in place for newborns delivered at home, birthing centers, or hospitals without hearing screening facilities.
Timing of screening All infants should have hearing screening before 1 mo of age. Infants who do not pass the newborn screening should undergo audiologic and medical evaluation before 3 mo of age.
Treatment
Early intervention services for hearing-impaired infants should meet the individualized needs of the infant and family, including acquisition of communication competence, social skills, emotional well-being, and positive self-esteem. Early intervention comprises evaluation for amplification or sensory devices, surgical and medical evaluation, and communication assessment and therapy.
Cochlear implants are usually considered for children with severe-to-profound hearing loss only after inadequate response to hearing aids.
Other relevant recommendations from the USPSTF Additional USPSTF recommendations regarding screening tests for newborns can be accessed at www.ahrq.gov/clinic/cps3dix.htm#pediatric.
For the full recommendation statement and supporting documents (including a summary of the evidence) please go to www.preventiveservices.ahrq.gov.
FIGURE
Clinical summary of USPSTF recommendation.
TABLE 1 What the USPSTF Grades Mean and Suggestions for Practice
Grade Grade Definitions Suggestions for Practice
A The USPSTF recommends the service. There is high certainty that the net benefit is substantial.
Offer/provide this service.
B
The USPSTF recommends the service. There is high certainty that the net benefit is moderate or there is moderate certainty that the net benefit is moderate to substantial.
C
The USPSTF recommends against routinely providing the service. There may be considerations that support providing the service in an individual patient. There is moderate or high certainty that the net benefit is small.
Offer/provide this service only if there are other considerations in support of the offering/providing the service in an individual patient.
D
The USPSTF recommends against the service. There is moderate or high certainty that the service has no net benefit or that the harms outweigh the benefits.
Discourage the use of this service.
I statement
The USPSTF concludes that the current evidence is insufficient to assess the balance of benefits and harms of the service. Evidence is lacking, of poor quality, or conflicting, and the balance of benefits and harms cannot be determined.
Read "Clinical Considerations" in the USPSTF Recommendation Statement. If offered, patients should understand the uncertainty about the balance of benefits and harms.
Assessment of Risk
Risk factors associated with a higher incidence of permanent bilateral congenital hearing loss include NICU admission for Ն2 days, several congenital syndromes, family history of hereditary childhood sensorineural hearing loss, craniofacial abnormalities, and certain congenital infections. However, ϳ50% of infants with permanent bilateral congenital hearing loss do not have any known risk factors.
Screening Tests
Screening programs should be conducted by using a 1-or 2-step validated protocol. A frequently used protocol requires a 2-step screening process, which includes otoacoustic emissions (OAEs) followed by auditory brainstem response (ABR) in those who failed the first test. Equipment should be well maintained, staff should be thoroughly trained, and quality-control programs should be in place to reduce avoidable false-positive test results. Programs should develop protocols to ensure that infants with positive screening-test results receive appropriate audiologic evaluation and follow-up after discharge. Newborns delivered at home, birthing centers, or hospitals without hearing screening facilities should have some mechanism for referral for newborn hearing screening, including tracking of follow-up.
Treatment
Early intervention services for hearing-impaired infants should be designed to meet the individualized needs of the infant and family, including acquisition of communication competence, social skills, emotional well-being, and positive self-esteem. Early intervention includes evaluation for amplification or sensory devices, surgical and medical evaluation, and communication assessment and therapy. In recent years, cochlear implants have become more available for appropriate candidates; this surgery is usually considered in those with severe-toprofound hearing loss only after inadequate response to hearing aids.
Screening Intervals
All infants should have hearing screening before 1 month of age. Those infants who do not pass the newborn screening should undergo audiologic and medical evaluation before 3 months of age for confirmatory testing. Because of the elevated risk of hearing loss in infants with risk indicators, an expert panel has made a 2000 recommendation that these children should undergo periodic monitoring for 3 years. 1
OTHER CONSIDERATIONS
Implementation
Thirty-nine US states have enacted legislation related to universal newborn hearing screening (UNHS). These laws differ with respect to whether screening is mandated or encouraged, how results are reported, and how screening is funded.
Research Needs/Gaps
Additional studies detailing the correlation between childhood language scores and functional outcomes (eg, school attainment and social functioning) are needed.
DISCUSSION
Burden of Disease
The focus of UNHS programs is on congenital (as opposed to acquired or progressive) hearing loss that may not be detected in the newborn period. According to the 2000 statement from the Joint Committee on Infant Hearing (JCIH), hearing screening should identify infants at risk for specifically defined hearing loss that interferes with development. The targeted hearing loss for UNHS programs is permanent sensory or conductive hearing loss averaging 30 to 40 dB or more in the frequency region important for speech recognition (ϳ500 -4000 Hz). 1 PCHL occurs in 1 to 3 per 1000 live births.
The prevalence for PCHL is higher than for other conditions screened for in the newborn period. Children with hearing loss may have difficulty learning grammar, word order, idiomatic expressions, and other forms of verbal communication. 2 Delayed language and speech, low educational attainment, increased behavior problems, de- 
Level of Certainty Description
High
The available evidence usually includes consistent results from well-designed, well-conducted studies in representative primary care populations. These studies assess the effects of the preventive service on health outcomes.
The conclusion, therefore, is unlikely to be strongly affected by the results of future studies.
Moderate
The available evidence is sufficient to determine the effects of the preventive service on health outcomes, but confidence in the estimate is constrained by factors such as: the number, size, or quality of individual studies; inconsistency of findings across individual studies; limited generalizability of findings to routine primary care practice; or lack of coherence in the chain of evidence As more information becomes available, the magnitude or direction of the observed effect could change, and the change may be large enough to alter the conclusion. Low
The available evidence is insufficient to assess effects on health outcomes. Evidence is insufficient because of: the limited number or size of studies; important flaws in study design or methods; inconsistency of findings across individual studies; gaps in the chain of evidence; findings not generalizable to routine primary care practice; or a lack of information on important health outcomes More information may allow an estimation of effects on health outcomes.
The USPSTF defines certainty as "likelihood that the USPSTF assessment of the net benefit of a preventive service is correct." The net benefit is defined as benefit minus harm of the preventive service as implemented in a general, primary care population. The USPSTF assigns a certainty level on the basis of the nature of the overall evidence available to assess the net benefit of a preventive service.
creased psychosocial well-being, and poor adaptive skills are all associated with hearing loss in children. [1] [2] [3] Risk factors associated with a higher incidence of PCHL include NICU admission for Ͼ2 days; syndromes associated with hearing loss, such as Usher syndrome and Waardenburg syndrome; family history of hereditary childhood hearing loss; craniofacial abnormalities; and congenital infections such as cytomegalovirus, toxoplasmosis, bacterial meningitis, syphilis, herpes, and rubella. 1 However, ϳ50% of infants with PCHL do not have any known risk factors. 2, 4, 5 In studies that included data on ethnicity and socioeconomic status, there has been a higher incidence of PCHL among white American infants compared with infants in other, less well-represented minority groups regardless of the age at which the hearing loss was identified. 2 
Scope of Review
The USPSTF examined the evidence for (1) the efficacy of UNHS in improving the initiation of treatment by 6 months of age for average-and high-risk infants compared with targeted screening, (2) the efficacy of treatment on language and communication outcomes if started before 6 months of age for those infants not identified by targeted screening, and (3) the harms of universal screening. There has been no direct evidence comparing targeted and universal screening programs in average-and high-risk infants.
Accuracy of Screening Tests
There are 2 approaches to screening newborns for hearing loss: UNHS of all newborns and targeted screening of high-risk newborns. 2 All states that have hearingscreening programs use universal screening. Infants who do not pass the newborn screening tests are referred for confirmatory testing before a diagnosis of PCHL is made. Referral rates have been lower in programs staffed by dedicated technicians rather than volunteers and students. 2 Both OAEs and ABR tests are noninvasive and evaluate easily recorded physiologic activities in newborns that correlate with the degree of peripheral hearing sensitivity.
A large, good-quality community-based cohort trial showed that the 2-step approach to UNHS (OAEs followed by ABR for those who failed the first test) yielded a screening sensitivity of 0.92 and a specificity of 0.98. 4 
Effectiveness of Early Detection and/or Treatment
A nonrandomized, controlled trial consisting of infants at high and average risk yielded good-quality evidence that newborns who underwent UNHS had earlier referral, diagnosis, and initiation of treatment compared with those who were not screened. 5 The number of cases of PCHL referred before the age of 6 months for infants in the UNHS population was 19 times higher compared with that of the nonscreened infants. More children with true PCHL were referred to audiology services before 6 months of age if they were born during periods with UNHS, compared with children born during periods without screening. The odds ratio for early confirmation of hearing impairment before 10 months of age was 5.0 times greater for screened infants compared with nonscreened infants. The odds of initiating early management of hearing loss before 10 months of age was 8.0 times higher for screened infants compared with nonscreened infants.
For all infants involved in the aforementioned trial, an 8-year follow-up study was performed that followed infants with abnormal screening-test results at birth or later. 4 The proportion of infants with true hearing impairment who were referred before 6 months of age was 74% during periods with UNHS and 31% during periods without UNHS. After adjustment for the severity of hearing impairment, UNHS was even more strongly correlated with referral before 6 months of age. One additional case of PCHL was referred before 6 months of age for every 1969 infants in the UNHS population.
A community-based retrospective cohort trial yielded good-quality evidence that those children with bilateral permanent hearing impairment who had early diagnostic confirmation before 9 months of age and those who had UNHS (compared with those who had no screening) had moderately higher receptive language scores at 8 years of age. 6 One fair-quality retrospective cohort study examined children from 7 to 8 years of age who were fitted with hearing aids for congenital hearing impairment by the age of 4.5 years. The study found that age at diagnosis did contribute significantly to variance on receptive vocabulary but did not for other language, speech, or reading measures. 7 There is fair-quality evidence, based on a retrospective cohort study, that an earlier age at the time of enrollment into an early child hearing intervention program results in better outcomes for receptive and expressive language compared with those treated at a later age, after controlling for degree of hearing loss and degree of outcome impairment at program entry. 8 A fair-quality retrospective cohort study that analyzed children enrolled for at least 6 months in a diagnostic early intervention program showed that children enrolled before 11 months of age had stronger vocabulary and reasoning skills than children enrolled at later ages, after adjustment for family involvement, degree of hearing loss, and nonverbal IQ. 9 
Potential Harms of Screening and Treatment
Limited evidence is available about the harms of screening. A fair-quality retrospective cohort study showed no differences in anxiety and attitude toward infant scores for mothers of infants who passed and did not pass screening tests. 10 There is fair evidence, based on a prospective cohort study, that there is no significant difference in the level of concern of mothers whose infants failed the first and second hearing-screening tests. 2 One poor-quality case-control study examined infants who were at risk for hearing impairment, who failed a distraction stress test, or who were controls for the other 2 groups. Parent-reported concerns about language development, general development, and perceived vulnerability to ill health did not differ among the groups, and most negative emotions resolved after the child's definitive hearing test. 2 Evidence regarding the harms of treatment is also limited. The have been few immediate complications of surgery reported in case series and case reports of cochlear implant surgery in infants; however, an increased risk of meningitis that may persist for several years after implantation has been reported. Note that these case series reflect the use of a no-longer-manufactured cochlear implant. Furthermore, children with congenital cochlear abnormalities may have a predisposition to meningitis regardless of the use of cochlear implants. The overall complications of screening and treatment are estimated to be small.
Estimate of Magnitude of Net Benefit
There is good evidence that newborn hearing-screening testing is highly accurate and leads to earlier identification and treatment of infants with hearing loss. With regard to the yield of screening 10 000 newborns for hearing loss by using universal versus targeted screening, universal screening would yield 7 more cases diagnosed by 3 months of age (1 with risk factors and 6 without known risk factors). The number needed to screen to diagnose 1 case is 878 and 178 for UNHS and targeted screening programs, respectively. The number needed to screen to diagnose 1 additional case by 3 months of age is 1333 for UNHS. 2 
RECOMMENDATIONS OF OTHER GROUPS
The JCIH endorses early detection and intervention for infants with hearing loss through integrated, interdisciplinary state and national systems of UNHS, evaluation, and family-centered intervention. The JCIH 2000 position statement (and recently released 2007 statement) provides guidelines that include UNHS soon after birth, before hospital discharge, or before 1 month of age; diagnosis of hearing loss through audiologic and medical evaluation before 3 months of age; and intervention through interdisciplinary programs for infants with confirmed hearing loss before 6 months. 1, 11 The American Academy of Pediatrics Task Force on Newborn and Infant Hearing, the National Institute on Deafness and Other Communication Disorders, and the Centers for Disease Control and Prevention Early Hearing Detection and Intervention Program support the JCIH recommendations. [12] [13] [14] The American Academy of Audiology Task Force on the Early Identification of Hearing Loss agrees that the use of support personnel in newborn hearingscreening programs is an appropriate and often necessary strategy for achieving universal detection of congenital hearing loss. 15 The supervising audiologist should be experienced in both the development and maintenance of a UNHS program, including an understanding of technology options.
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